Metabolomics Clinical Trials

8 recruiting

Metabolomics Trials at a Glance

10 actively recruiting trials for metabolomics are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Boston, Gothenburg, and Guangzhou. Lead sponsors running metabolomics studies include Kaohsiung Medical University Chung-Ho Memorial Hospital, Karolinska Institutet, and KU Leuven.

Browse metabolomics trials by phase

Treatments under study

About Metabolomics Clinical Trials

Looking for clinical trials for Metabolomics? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metabolomics trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metabolomics clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness

Muscle WeaknessMetabolomicsCritical Illness+4 more
Technical University of Munich20 enrolled3 locationsNCT03810768
Recruiting

EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE

EpilepsyMetabolomicsProteomics+2 more
Karolinska Institutet1,500 enrolled6 locationsNCT07253701
Recruiting
Not Applicable

LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals

The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals
Zhejiang Cancer Hospital20 enrolled1 locationNCT07252362
Recruiting

Bio-significance of LPC16:0 in Fibromyalgia

PainMetabolomicsLipidomics+3 more
Kaohsiung Medical University Chung-Ho Memorial Hospital245 enrolled1 locationNCT04832100
Recruiting
Early Phase 1

Supplemental Oxygen in Pulmonary Embolism (SO-PE)

Venous ThromboembolismPulmonary EmbolismMetabolomics+1 more
Massachusetts General Hospital80 enrolled1 locationNCT05891886
Recruiting
Not Applicable

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome

Body CompositionMetabolic SyndromeBlood Pressure+5 more
KU Leuven50 enrolled1 locationNCT06951386
Recruiting

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Lung CancerLung Cancer (NSCLC)Lung+1 more
The First Affiliated Hospital of Guangzhou Medical University2,500 enrolled1 locationNCT06843707
Recruiting

Microbiome and Malnutrition in Pregnancy

MetabolomicsMalnutritionPregnancy Complications+9 more
The Hospital for Sick Children800 enrolled2 locationsNCT04992104
Recruiting

Evaluation of interstitial fluid (ISF) Collection Methods and Metabolite Profiles in Healthy Humans.

Metabolomics for biomarker profiles
Nutromics Operations30 enrolled1 locationACTRN12624001347550
Recruiting

Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With ADHD

MetabolomicsMethylphenidate
National Taiwan University Hospital160 enrolled1 locationNCT06073470